MedTrace Logo

Screening of Gonococcal and Chlamydial Infections in the Third Trimester

NCT03073538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1691

Last updated 2019-02-21

No results posted yet for this study

Summary

Untreated maternal infection with gonorrhea and/or chlamydia can have serious complications in pregnancy and the neonatal period. In Ontario, routine screening for these infections is done in the first trimester of pregnancy, positive cases are treated with antibiotics, and all newborns are given antibiotic eye ointment within 24 hours of birth. Recently, the Canadian Pediatric Society recommended stopping universal prophylaxis for newborns, with instead, focus on screening and treatment of these infections in pregnancy. Given that these infections can occur at any time in pregnancy, and exposure at delivery provides a significant risk to infants, more information is needed about the rates of infection throughout pregnancy and health-care provider compliance with guidelines to make this change without undue risk. With this information optimal timing of testing can be evaluated.

Conditions

  • Gonococcal Infection
  • Chlamydia Infections

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Mark Yudin, MD · Unity Health Toronto

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-02-28
Completion
2019-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03073538 on ClinicalTrials.gov